Company Overview

Location Kyoto University Med-Pharm Collaboration Building #415,
46-29 Yoshida-Shimo-Adachi-cho, Sakyo-ku,
Kyoto 606-8501, Japan [Map]
Management Yasumich Hitoshi, M.D., Ph.D., CEO/CTO
Ryosuke Gonotsubo, MBA, COO/CFO
Shin Kaneko, M.D., PhD., Founder, Director
Hiroyuki Ueno, Ph.D., Director
Established August 24, 2015
Shareholders Kyoto University Innovation Capital Co., Ltd.,
Future Venture Capital Co., Ltd.,
Yasumichi Hitoshi, Shin Kaneko, Ryosuke Gonotsubo, and others
Founder Yoshimoto Katsura, Professor emeritus, Kyoto University
Shin Kaneko, Professor, Kyoto University

What’s “Thyas”

  • The organ where T cells learn how to recognize foreign antigens but not self, is called “Thymus”. Mature T cells show antigen specific target recognition, and the pronunciation of “as” is reminiscent of a Japanese word “tomorrow” or “future.” “Thyas” is a coined word made from “Thymus” & “as” (antigen specific and tomorrow), meaning “the place where next-gen T cell therapy is born.”
  • Thyas is a genus of moths in the family Erebidae, and found mostly in Asia including Japan. Our company logomark is designed after Thyas, representing T cell receptor chains (center) and associated molecules (side). It is also an image of a dancing lady with Kimono fabricated in Kyoto.


Contact Us

Fields marked with an * are required
Phone - -
Affiliation department
(or faculty / department name)

The personal information submitted herein is used only for the purpose to contact you from our staff to deal with the subjects you asked for and never used for any other purposes.